Articular compromise after chikungunya fever in a second tier hospital during the 2015 epidemic. Asunción, Paraguay
Abstract
Introduction: Chikungunya fever is a viral disease caused by an alphavirus from the Togaviridae family, that is transmitted by mosquitoes of the genus Aedes. It is manifested by fever, skin rash and joint pain. A high percentage of patients develop a persistent polyarthritis that can last for months or even years. Objectives: To describe the clinical and epidemiological characteristics of patients diagnosed with arthritis after Chikungunya fever. Materials and methods: A retrospective, cross-sectional study of patients who were seen at the District Hospital of Villa Elisa during the first semester of 2015, and were diagnosed with Chikungunya fever. Results: A total of 26 patients from Asunción were included, of which 92% were women, with an average age of 47.2 years. The predominant symptoms were arthralgia (92.3%) and headache (76.9%). Joint symptoms started on average 14 days after the onset of fever. The proximal metacarpophalangeal and interphalangeal joints were affected in 73% of the patients, the radiocarpal and knee joints in 76.9%, shoulders in 50% and feet in 92.3%. All patients were treated with NSAIDs and 76.9% received treatment with prednisone, with partial or total improvement of symptoms in 92.3% of the cases. Two patients (7.6%) required Methotrexate due to the persistence of arthritis after corticosteroids were discontinued. Conclusion: Chikungunya fever is a major health issue in our country, especially due to its ability to generate rheumatological complications in the medium and long run. We must pay special attention to this pathology since the chronic joint compromise can lead to disability and labor absenteeism, which would translate into overload of the public health system.Downloads
References
(1) La eventual introducción del virus chikungunya en las Américas [Internet]. Washington, D.C: Organización Panamericana de la Salud; 2011 [cited 25 March 2018]. Available from: http://www1.paho.org/hq/dmdocuments/CHIKV_Spanish.pdf
(2) Guía para el manejo clínico de la enfermedad producida por el virus del Chikungunya. Pediatr. (Asunción) [Internet]. 2015 Apr[cited 2018 Mar 25] ; 42( 1 ): 54-69. Available from: http:/scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S1683-98032015000100009&lng=en. http://dx.doi.org/10.18004ped.2015.abril.54-69
(3) Javelle E, Tiong T, Leparc-Goffart I, Savini H, Simon F. Inflammation of the external ear in acute chikungunya infection: Experience from the outbreak in Johor Bahru, Malaysia, 2008. 2014.
(4) Moro M, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. Journal of Infection. 2012;65(2):165-172.
(5) Rodríguez-Morales Alfonso J., Anaya Juan-Manuel. Impacto de las arbovirosis artritogénicas emergentes en Colombia y América Latina. Rev.Colomb.Reumatol. [Internet]. 2016 Sep [cited 2018 Mar 25] ; 23( 3 ): 145-147. Available from: http://wwwscielo.org.co/scielo.php?script=sci_arttext&pid=S012181232016000300001&lng=en. http://dx.doi.org/10.1016/j.rcreu.2016.08.001.
(6) Javelle E, Ribera A, Degasne I, Gaüzère B, Marimoutou C, Simon F. Specific Management of Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion Island from 2006-2012. PLOS Neglected Tropical Diseases. 2015;9(3):e0003603.
(7) Plan de Contingencia de Dengue, ZIKA y Chikungunya 2017 [Internet]. Asunción: nstituto de Medicina Tropical; 2017 [cited 25 March 2018]. Available from: https://www.mspbs.gov.py/dependencias/imt/adjunto/adb710-denguezikaychicuguya2017 corregido.pdf
(8) Krutikov M, Manson J. Chikungunya Virus Infection: An Update on Joint Manifestations and Management. Rambam Maimonides Medical Journal. 2016;7(4):e0033.
(9) Ganu M, Ganu A. Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up. Journal of the Association of Physicians of India [Internet]. 2011 [cited 25 March 2018];59:83-86. Available from: http://www.japi.org/february_2011/oa_post-chikungunya_chronic.pdfChopra A, Saluja M, Venugopalan A. Effectiveness of Chloroquine and Inflammatory Cytokine R esponse in Patients With Early Persistent Musculoskeletal Pain and Arthritis Following Chikungunya Virus Infection. Arthritis & Rheumatology. 2014;66(2):319-326.
(10) Chopra A, Saluja M, Venugopalan A. Effectiveness of Chloroquine and Inflammatory Cytokine Response in Patients With Early Persistent Musculoskeletal Pain and Arthritis Following C hikungunya Virus Infection. Arthritis & Rheumatology. 2014;66(2):319-326.
Copyright (c) 2017 Paraguayan Journal of Rheumatology

This work is licensed under a Creative Commons Attribution 4.0 International License.